春立医疗(01858)发布前三季度业绩 归母净利润1.92亿元 同比增长213.21%

Core Viewpoint - Spring Medical (01858) reported significant growth in its financial performance for the first three quarters of 2025, indicating strong operational momentum and profitability [1] Financial Performance - The company achieved operating revenue of 756 million yuan, representing a year-on-year increase of 48.75% [1] - The net profit attributable to shareholders of the listed company reached 192 million yuan, reflecting a substantial year-on-year growth of 213.21% [1] - Basic earnings per share were reported at 0.5 yuan [1]